-
Company Profile
Antares Pharma Inc – Company Profile
Antares Pharma Inc (Antares Pharma), a subsidiary of Halozyme Therapeutics Inc, is a specialty pharmaceutical company engaged in the development, manufacturing, and commercialization of pharmaceutical products and technologies. The company’s portfolio encompasses around novel therapeutic products for therapy areas related to polyarticular juvenile idiopathic arthritis, severe rheumatoid arthritis, severe recalcitrant psoriasis, migraine and cluster headache. It also develops products to reduce the risk of preterm birth in pregnant women. It caters its subcutaneous injection technology platforms to both generic and...
Add to Basket -
Product Insights
Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Prostate cancer usually occurs in older men. Its symptoms include problems while urinating, decreased force in the stream of urine, blood in the urine, pain in the lower back, hips, or thighs, bone pain, and erectile dysfunction. The Prostate Cancer pipeline market research report provides comprehensive information on the therapeutics under development for Prostate Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the...
-
Product Insights
Net Present Value Model: Otrexup
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Otrexup Drug Details Methotrexate (Otrexup) is...
-
Product Insights
Net Present Value Model: Tlando XR
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Tlando XR Drug Details LPCN-1111 is...
-
Product Insights
Net Present Value Model: Xyosted
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Xyosted Drug Details Testosterone enanthate (Xyosted)...
-
Product Insights
Net Present Value Model: Hydrocortisone
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Hydrocortisone Drug Details Hydrocortisone (ATRS-1902) is...
-
Product Insights
Net Present Value Model: Nocdurna
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Nocdurna Drug Details Desmopressin acetate (Minirinmelt...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – hydrocortisone
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry hydrocortisone Drug Details Hydrocortisone (ATRS-1902) is under development for the treatment of adrenal crisis...
-
Sector Analysis
United States Insulin Delivery Market Outlook to 2025
GlobalData’s “United States Insulin Delivery Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Insulin Delivery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Insulin Pens and Insulin Pumps. The United States Insulin Delivery Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided...
-
Sector Analysis
North America Insulin Delivery Market Outlook to 2025
GlobalData’s “North America Insulin Delivery Market Outlook to 2025” is a comprehensive databook report, covering key market data on the North America Insulin Delivery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Insulin Pens and Insulin Pumps. The North America Insulin Delivery Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided...